CRL Reports $995.8M Revenue, $(0.30) GAAP EPS, $2.06 Non-GAAP EPS, Reaffirms 2026 Guidance, Repurchases $200M Stock, Divests CDMO and Cell Solutions
Charles River Laboratories International, Inc. · SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH · Now $182.07
-17% in 7d after detection
Post-detection moves
1h
—
1d
-2.2%
3d
-7.1%
7d
-17%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS